Disclosed are novel 5-thia-1,4-diazabicyclo[4.2.0]octane-3,8-dioxo β-lactam analogs of the general formula I
wherein
R¹is hydrogen or halo;
R²is hydrogen, halo, amino, PhCH₂CONH, PhOCH₂CONH, phthalimido, o-MeNHCO-C₆H₄-CONH, isoxazolylcarboxamido;
R³is hydrogen, alkyl, benzyl, heterocycle, e.g. isoxazole, pyrazole etc., and
nmay be 1 or 2.
They may be used as intermediates in preparing novel β-lactam analogs or as active substances in formulations for antimicrobial therapy.
公开了通式 I 的新型 5-
硫杂-1,4-二氮杂
双环[4.2.0]辛烷-3,8-二氧代 β-内酰胺类似物
其中
R¹ 是氢或卤代
R²为氢、卤素、
氨基、PhCH₂CONH、PhOCH₂CONH、邻苯二甲
酰亚胺、邻-MeNHCO-C₆H₄-CONH、
异噁唑甲酰胺基;
R³ 是氢、烷基、苄基、杂环,如
异噁唑、
吡唑等,以及
可为 1 或 2。
它们可用作制备新型 β-内酰胺类似物的中间体,或用作抗菌治疗配方中的活性物质。